Biden’s Drug Cost Cap to Save Average $1,500 Next Year: Analysis

TL/DR –

The Biden administration’s cap on the cost of insulin and epinephrine is projected to save Americans with diabetes and severe allergies an average of $1,500 each next year, according to an analysis by the Department of Health and Human Services. The new rule, set to take effect in January 2023, will limit the co-pay for these drugs to $35 per month for those with health insurance. This move is expected to affect around 30 million people who rely on these life-saving medications.

Biden’s Drug Cost Cap to Save Millions Average $1,500 Next Year: Analysis

The Biden administration’s cap on drug costs could potentially save millions of individuals an average of $1,500 next year, according to a recent analysis. This major initiative by the US government aims to alleviate the financial burden on individuals for their essential medicines. The move is part of Biden’s larger healthcare reform, focusing on affordability and accessibility for all.

—
Read More US Economic News